Skip to main content
. 2022 Nov 2;42(12):1093–1100. doi: 10.1007/s40261-022-01210-1

Fig. 3.

Fig. 3

Mean plasma citrulline concentrations pre-dose and after the first and sixth dose in subjects receiving subcutaneous glepaglutide 5 mg and 10 mg once weekly